ctrl K

Watchlist Price Alert

Quince Therapeutics Inc. (QNCX)

NASDAQ: QNCX · Real-Time Price · USD

1.42

0.22 (18.33%)

At close: Jun 13, 2025, 3:59 PM

1.30

-8.13%

After-hours: Jun 13, 2025, 05:59 PM EDT

Quince Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	322K	175K	344K	332K	188K	51K	45K
Gross Profit	n/a	-322K	-175K	-344K	-332K	-188K	-51K	-45K
Operating Income	-57.28M	-34.62M	-52.02M	-90.32M	-78.89M	-39.17M	-12.12M	-10.37M
Interest Income	2.93M	3.48M	1.07M	620K	2.04M	2.19M	806K	n/a
Pretax Income	-56.74M	-31.58M	-51.94M	-89.94M	-76.85M	-36.98M	-12.48M	-12.23M
Net Income	-56.83M	-31.39M	-51.66M	-89.33M	-76.85M	-36.79M	-12.48M	-12.23M
Selling & General & Admin	17.58M	15.39M	26.01M	29.52M	17.59M	8.95M	2.03M	1.27M
Research & Development	18.59M	9.45M	25.18M	60.8M	61.31M	30.21M	10.09M	9.1M
Other Expenses	21.11M	9.78M	-997K	-247K	n/a	n/a	n/a	n/a
Operating Expenses	57.28M	34.62M	51.19M	90.32M	78.89M	39.17M	12.12M	10.37M
Interest Expense	n/a	n/a	568K	n/a	n/a	n/a	957K	1.64M
Selling & Marketing Expenses	n/a	-2.3M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	34.62M	51.19M	90.32M	78.89M	39.17M	12.12M	10.37M
Income Tax Expense	87K	-197K	-284K	-620K	2.17M	-188K	357K	1.86M
Shares Outstanding (Basic)	43.26M	37.24M	33.5M	29.72M	29.18M	19.03M	21.55M	21.55M
Shares Outstanding (Diluted)	43.26M	37.24M	33.5M	29.72M	29.18M	19.03M	21.55M	21.55M
EPS (Basic)	-1.31	-0.84	-1.54	-3.01	-2.63	-1.93	-0.58	-0.57
EPS (Diluted)	-1.31	-0.84	-1.54	-3.01	-2.63	-1.93	-0.58	-0.57
EBITDA	-56.55M	-31.26M	-52.02M	-89.97M	-78.56M	-38.98M	-12.07M	-10.32M
EBIT	-56.74M	-31.58M	-50.09M	-90.32M	-76.85M	-36.98M	-11.52M	-10.37M
Depreciation & Amortization	n/a	322K	175K	344K	332K	188K	51K	45K